SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%
News
ICCC
--
0.00%
--
Edited Transcript of ICCC earnings conference call or presentation 14-May-20 1:00pm GMT
Q1 2020 ImmuCell Corp Earnings Call
Thomson Reuters StreetEvents · 05/18 15:48
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/14 19:14
ImmuCell Corporation to Present at Lytham Partners Virtual Investor Conference
ImmuCell Corporation (NASDAQ: ICCC) a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, today announced it will participate in a
PR Newswire · 05/14 17:35
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
GlobeNewswire · 05/14 13:42
ImmuCell reports Q1 results
ImmuCell (NASDAQ:ICCC): Q1 GAAP EPS of -$0.02. Revenue of $4.91M (+11.3% Y/Y) Press Release
seekingalpha · 05/14 01:10
ImmuCell Q1 EPS $(0.020) Down From $0.030 YoY, Sales $4.910M Up From $4.411M YoY
ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.020) per share. This is a 166.67 percent decrease over earnings of $0.030 per share from the same period last year. The company reported $4.910 million in sales
Benzinga · 05/13 20:10
ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2020
PORTLAND, Maine, May 13, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets.
GlobeNewswire · 05/13 20:05
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) gained about 6% for the week.
Benzinga · 05/10 19:40
ImmuCell to Announce Unaudited Financial Results for First Quarter of 2020
ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, will repo
GlobeNewswire · 05/07 16:00
Does ImmuCell Corporation (NASDAQ:ICCC) Have A High Beta?
Simply Wall St. · 04/20 15:52
ImmuCell Receives $938,000 in Support under the Paycheck Protection Program
GlobeNewswire · 04/14 13:00
The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend Initiation
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 6.)
Benzinga · 04/07 11:57
The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
Benzinga · 04/03 12:36
The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 2) BELLUS Health Inc (NASDAQ: BLU)
Benzinga · 04/03 11:36
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020
GlobeNewswire · 04/02 21:29
ImmuCell Announces Prelim. Product Sales Of $500K For Quarter Ended Mar. 31
Benzinga · 04/02 20:30
ImmuCell Announces Refinancing of its Bank Debt
GlobeNewswire · 03/11 21:05
Why ImmuCell Corporation's (NASDAQ:ICCC) CEO Pay Matters To You
Simply Wall St. · 03/01 14:09
NVAX, SGMO among premarket gainers
Seeking Alpha - Article · 02/28 14:20
Edited Transcript of ICCC earnings conference call or presentation 19-Feb-20 2:00pm GMT
Thomson Reuters StreetEvents · 02/26 02:04